Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
A Standard patent application filed on 14 October 1999 credited to Ganguly, Ashit K.
;
Mccormick, Jinping
;
Girijavallabhan, Viyyoor M.
;
Bennett, Frank
;
Saksena, Anil K.
;
Lovey, Raymond G.
Details
Application number :
11975
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
Inventor :
Ganguly, Ashit K.
;
Mccormick, Jinping
;
Girijavallabhan, Viyyoor M.
;
Bennett, Frank
;
Saksena, Anil K.
;
Lovey, Raymond G.
Agent name :
Griffith Hack
Address for service :
GPO Box 4164 SYDNEY NSW 2001
Filing date :
14 October 1999
Associated companies :
Applicant name :
Schering Corporation
Applicant address :
2000 Galloping Hill Road Kenilworth NJ 07033-0530 United States Of America